Premature ovarian insufficiency (POI)
- Specialty
- Gynaecology · Endocrinology & cycle
- Images
- Histology & cytology 1
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (1)
Histology & cytologyDefinition
- Premature ovarian insufficiency is a loss of ovarian function before the age of 40, with amenorrhoea, low oestradiol and raised FSH.
- Because the degree of ovarian impairment may fluctuate over time, the former term premature ovarian failure has largely been abandoned.
Occurrence & epidemiology
Epidemiology
- The prevalence of non-iatrogenic POI is reported as about 1% in older studies and about 3.5% in recent publications.
Aetiopathogenesis
Aetiology and pathogenesis
- The cause often remains unclear: idiopathic cases are estimated at about 39–67%, genetic causes at 10–30%, autoimmune causes at 5–17% and iatrogenic causes at 6–47%.
- Genetic causes include Turner syndrome and FMR1 premutation; associated autoimmune diseases include Addison disease, Hashimoto thyroiditis and type 1 diabetes.
- Further causes are iatrogenic gonadotoxic exposure, metabolic disorders such as galactosaemia and infections such as mumps or tuberculosis.
Clinical features
- The leading symptom is primary or secondary amenorrhoea, sometimes with irregular bleeding, often with oestrogen-deficiency symptoms such as hot flushes, vaginal dryness and decreased libido.
- Oestrogen deficiency reduces bone density with increased fracture risk and raises cardiovascular risk; spontaneous pregnancy is possible but occurs in only about 5–10% of affected women.
Diagnosis
- According to the 2024 ESHRE guideline, disordered cycles (amenorrhoea or irregular cycles) for at least 4 months and an FSH above 25 IU/L are diagnostic; FSH is measured again after 4–6 weeks if the result is unclear.
- Other causes of secondary amenorrhoea such as pregnancy and hypothyroidism are excluded beforehand.
- AMH is not a primary diagnostic test but can support the diagnosis when FSH results are inconclusive; in non-iatrogenic POI, chromosomal analysis, for example to detect Turner syndrome, and FMR1 testing are part of the work-up.
Treatment principles
- The mainstay is hormone replacement therapy at least until the average age of natural menopause to protect bone, the cardiovascular system and quality of life.
- Investigation of the cause includes karyotyping, testing for a fragile X premutation and screening for autoimmune disease.
- Counselling addresses fertility wishes, contraception and psychological burden, as spontaneous ovulation is rare but possible.
Specific treatment regimens with drugs and doses are covered in the GynFuchs app.
Keep learning in the app
Further reading (selection)
Cross-references
Keep learning
Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.
Related pages: Premenstrual syndrome (PMS/PMDD) · Precocious and delayed puberty · Female infertility
Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.